CSIMarket
 
State Street Corp  (STT)
Other Ticker:  
 
    Sector • Financial    Industry • Regional Banks
   Industry • Regional Banks
   Sector • Financial
 
Price: $77.8500 $-1.00 -1.268%
Day's High: $79.3 Week Perf: -1.62 %
Day's Low: $ 77.72 30 Day Perf: -4.14 %
Volume (M): 1,856 52 Wk High: $ 85.89
Volume (M$): $ 144,458 52 Wk Avg: $65.52
Open: $78.88 52 Wk Low: $48.62



 Market Capitalization (Millions $) 28,851
 Shares Outstanding (Millions) 371
 Employees 29,970
 Revenues (TTM) (Millions $) 12,046
 Net Income (TTM) (Millions $) 2,402
 Cash Flow (TTM) (Millions $) 901
 Capital Exp. (TTM) (Millions $) 560

State Street Corp
State Street Corporation is a financial holding company organized under the laws of the Commonwealth of Massachusetts. State Street, through its subsidiaries, provides a full range of products and services for sophisticated global investors. State Street was organized in 1970 and conducts its business principally through its subsidiary, State Street Bank and Trust Company, which traces its beginnings to the founding of the Union Bank in 1792. The charter under which State Street Bank now operates was authorized by a special act of the Massachusetts Legislature in 1891, and its present name was adopted in 1960.


   Company Address: One Lincoln Street Boston, 2111 MA
   Company Phone Number: 786-3000   Stock Exchange / Ticker: NYSE STT
   STT is expected to report next financial results on March 02, 2020. Next quarterly dividend payout on April 16, 2020.
 

State Street's Segments
 
Investment Serv.
 Segment    89.08 % of total Revenue
Investment Mgmt.
 Segment    10.92 % of total Revenue
 

State Street's Operating Statistics Decrease / Increase
       
Interest rate Spread 0.00 -  Interest rate Spread Decline   
Net interest margin 0.96 -27.82 %  Net interest margin Decline   
Nonperforming Assets Ratio 0.00    - 
Allowance for Credit Losses 0.00    - 
Tier1 Capital Ratio 14.90 -13.87 %  Tier1 Capital Ratio Decline   
Total Capital Ratio 17.00 -14.14 %  Total Capital Ratio Decline   
Leverage Ratio 6.00 -16.67 %  Leverage Ratio Decline   
Tangible Common Equity Ratio 5.83    Tangible Common Equity Ratio Growth  18.37 % 
Efficiency Ratio 74.91    Efficiency Ratio Growth  2.23 % 
Equities Assets under Mgmt.(millions $) 0.00 -  Equities Assets under Mgmt.(millions $) Decline   
Fixed income Assets under Mgmt.(millions $) 0.00 -  Fixed income Assets under Mgmt.(millions $) Decline   
Shortterm investments Assets under Mgmt.(millions $) 0.00 -  Shortterm investments Assets under Mgmt.(millions $) Decline   
Other Assets under Mgmt. (millions $) 0.00 -  Other Assets under Mgmt. (millions $) Decline   
Total Assets under Mgmt.(millions $) 0.00 -  Total Assets under Mgmt.(millions $) Decline   
• View Complete Report

Remedent, Inc.

Remedent, Inc announced third quarter operating loss of $-0.123016 millions

Weak demand caused increase in losses for the third quarter, company's loss per share grew to $-0.01 from $0.00 where Sales fell by -24.18 % to $0.26 millions from $0.35 millions a year ago.

Nanoviricides, Inc.

Nanoviricides, Inc announced second quarter operating shortfall of $-1.634432 millions

In the second quarter Nanoviricides, Inc increased losses of $-0.50 per share compare to $-0.03 a year ago and increased losses from $-0.41 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Senmiao Technology Ltd

Company Fail to Break-even Despite Surge in Sales

Senmiao Technology Ltd announced very strong Sales growth of 1208.31 % year on year to $2.75 millions in the third quarter, but increased losses at $-0.18.
Allied Healthcare Products Inc

Allied Healthcare Products Inc announced second quarter operating shortfall of $-1.512455 millions

Lower demand led to lower revenues and higher losses, in the second quarter company increased losses to $-0.38 per share, while Sales fell by -9.83 % to $7.31 millions, year on year.
Angiosoma, Inc.

Break-even, Topline Tumbles

In the first quarter Angiosoma, Inc reached break-even of $0.00 per share compare to $-0.19 a year ago and from $-0.15 per share from the previous quarter.

Sales fell sharply to $0.00 millions from $8.11 millions in the same quarter a year ago and sequentially from $7.98 millions.






Customers Net Income grew by STT's customers Net margin grew to
133.39 % 9.28 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   
Major Competitors Stock performance

5 Days Decrease / Increase
     
ASB      0% 
WTFC        1.65% 
KEY        0.93% 
CATY   -0.3%    
BBVA   -0.18%    
BOH        1.07% 
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

 Stocks


Event Calendar

ATOM's Profile

Stock Price

ATOM's Financials

Business Description

Fundamentals

Charts & Quotes

ATOM's News

Suppliers

ATOM's Competitors

Customers & Markets

Economic Indicators

ATOM's Growth

Company Segments

 Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness
Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

 Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

 News


At a Glance

Stocks

Economy

Industries

Other
Help


Sitemap

Advertise

About us

 Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071